Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Wichita Falls, TX MSA — September 2026
Wichita Falls contracts while Texas life sciences investment flows elsewhere.
Wichita Falls MSA employment fell 1.2% year-over-year to 58,800 jobs and unemployment rose to 4.5%, even as Clinical Research Associate pay nationally climbed to a $90,956 median — a gap this thinly-staffed metro shows little capacity to close locally.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro unemployment rate: 4.5% — Up from 3.9% a year ago; vs 4.0% statewide Texas
- Metro nonfarm employment: 58,800 — Down 1.2% YoY, one of two shrinking TX metros
- CRA advertised pay, metro vs national: $81,374 — vs $90,956 national median, both trending up
- Texas pharma establishment growth since 2019: 56.2% — 415 establishments, concentrated outside this metro
Key takeaways
Wichita Falls offers no local life sciences labor pool to tap.
None of the metro's largest employers operate in pharma, biotech, or medical device manufacturing, meaning any specialized hire here is effectively a relocation or remote hire, not a local one. Headcount planning for this geography should assume national-market competition, not metro-market competition, for scientific and regulatory talent.
CRA pay gap versus national median may understate true scarcity.
Metro advertised pay for Clinical Research Associates trails the national figure by roughly 10.5%, but with so few comparable roles posted locally, this gap likely reflects a thin sample rather than a genuine regional discount. Treat metro-specific advertised pay here as directional, not a reliable floor for offers.
Metro job contraction raises the bar for retention economics elsewhere.
A 1.2% year-over-year employment decline and rising unemployment (4.5%) in a metro otherwise outperformed by the rest of Texas suggests local labor softening is idiosyncratic, not regional. Leaders benchmarking Texas-wide life sciences compensation should isolate Wichita Falls from stronger-growth metros like Houston when interpreting state-level wage trends.
State biomanufacturing boom bypasses this metro entirely.
Houston's Generation Park is absorbing over $8.8B in combined Lilly and Bristol Myers Squibb manufacturing investment, concentrating Texas life sciences wage pressure and talent competition hundreds of miles away. Wichita Falls remains a cost-stable option for back-office, quality, or remote clinical functions precisely because it sits outside this investment corridor.
Median advertised pay by role — Wichita Falls, TX MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $84,986 | $125,310 | $136,499 | Significant increase | $131,354 |
| Clinical Research Associate * | $58,220 | $81,374 | $98,325 | Significant increase | $90,956 |
| Lab Technician * | $37,740 | $45,314 | $49,226 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $70,793 | $95,949 | $116,373 | Moderate decline | $104,000 |
| Clinical Data Manager * | $96,493 | $122,953 | $136,780 | Stable | $123,031 |
| Biostatistician * | $104,135 | $141,493 | $163,775 | Significant increase | $133,322 |
| Validation Engineer * | $82,458 | $105,350 | $113,458 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Wichita Falls MSA contracted to 58,800 nonfarm jobs in August, one of only two shrinking Texas metros, while the unemployment rate climbed to 4.5% as the metro's manufacturing and aerospace-casting base (Howmet, Pratt & Whitney) competes with retail and logistics for a limited labor pool. No life sciences employer appears among the metro's largest listed employers, meaning scientific, clinical, and regulatory hiring here draws almost entirely from outside talent pools rather than local supply.
What it means
Metro-level contraction signals a thin local bench for credentialed scientific and regulatory roles, reinforcing that any R&D, quality, or regulatory build-out in or near Wichita Falls will likely require relocation incentives or remote/hybrid structures rather than local sourcing. Clinical Research Associate advertised pay sits meaningfully below the national median ($81,374 versus $90,956), which may reflect both lower cost-of-living positioning and genuine scarcity-driven compression given the metro's small life sciences footprint. Organizations should evaluate whether Wichita Falls functions as a cost-advantaged satellite location for clinical or quality operations, or whether the absence of a local life sciences cluster makes CRO/CDMO partnerships the more defensible near-term choice over direct hire.
Looking ahead
Worth watching: Metro unemployment has risen from 3.9% to 4.5% over the past year while statewide Texas unemployment holds near 4.0%. Continued metro-level softening could eventually loosen adjacent labor markets (Dallas-Fort Worth commuting distance) for remote or hybrid life sciences roles.
Emerging pressure point: Sheppard Air Force Base and aerospace-casting employers (Howmet, Pratt & Whitney) are actively competing for technical and quality-control talent locally. Life sciences employers considering quality or manufacturing-adjacent roles in this metro should expect wage competition from aerospace, not pharma peers.
Potential inflection point: Texas's pharma subsector grew 56.2% in establishment count since 2019, concentrated outside Wichita Falls; watch whether any of that expansion extends toward North Texas satellite sites as Dallas-area capacity tightens. A single CDMO or device manufacturer siting decision could reshape this metro's talent calculus quickly.
Early indicator: National CRA advertised pay is rising significantly even as Wichita Falls shows a wide discount to the national figure; a narrowing gap over coming months would signal remote-hire competition is finally reaching this geography.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.